Delisting risk
AEMD · NASDAQ · Medical - Devices

Aethlon Medical (AEMD)

Developer of the investigational Hemopurifier for virus and extracellular-vesicle removal.

$1.71
Pre-market−0.13 (−7.07%)
At close$1.84(0.00%)

Breakdown13F · 13D/G · Form 4

Institutions12 holders · as of Mar 31, 20262.69%14.2K shares
Insiders4 holders · as of Jul 1, 20263.42%18.0K shares
Otherremainder93.89%494.5K shares

526.7K company shares as of Aug 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (711.1K in the company's Sep 3, 2026 report, 526.7K elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Angela RossettiInsiderdirector
1.00%5,241Form 4filed Apr 21, 2026
Geode Capital Management, LLCInstitution
0.93%24,36413Fas of Mar 31, 2026
Edward G. BroennimanInsiderdirector
0.85%4,473Form 4filed Jul 1, 2026
Chetan ShahInsiderdirector
0.79%4,168Form 4filed Jul 1, 2026
Nicolas GikakisInsiderdirector
0.78%4,133Form 4filed Jul 1, 2026
Ikarian Capital, LLCInstitution
0.55%14,36413Fas of Mar 31, 2026
Shay Capital LLCInstitution
0.54%14,12413Fas of Mar 31, 2026
XTX Topco LtdInstitution
0.51%13,34213Fas of Mar 31, 2026
Morgan StanleyInstitution
0.08%2,04713Fas of Mar 31, 2026
Tower Research Capital LLC (TRC)Institution
0.06%1,61113Fas of Mar 31, 2026
UBS Group AGInstitution
0.03%89513Fas of Mar 31, 2026
Group One Trading, L.P.Institution
0.00%1413Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.00%1013Fas of Mar 31, 2026
Caitong International Asset Management Co., LtdInstitution
0.00%813Fas of Mar 31, 2026
Wells Fargo & Company/MNInstitution
0.00%313Fas of Mar 31, 2026
Danske Bank A/SInstitution
0.00%113Fas of Mar 31, 2026
Armistice Capital Master Fund Ltd.Strategic
3.80% of class, as filed13Gfiled Jan 24, 2020
Armistice Capital, LLCStrategic
9.99% of class, as filed13Gfiled May 15, 2025
Empery Asset Management, LPInstitution
4.99% of class, as filed13G/Afiled Jan 16, 2018
Mitchell P. KopinInsider
7.70% of class, as filed13Gfiled Sep 10, 2025
Richard AbbeInsider
1.22% of class, as filed13G/Afiled Feb 22, 2021
Sachs Investment Group, LLCInstitution
11.50% of class, as filed13D/Gfiled Feb 13, 2018
Sabrina Martucci Johnson1Insiderdirector
0.00%8Form 4filed Mar 31, 2022
Charles J. Jr Fisher2Insiderdirector, officer: Chief Executive Officer
0.00%5Form 4filed Apr 2, 2021
Guy F. Cipriani2Insiderdirector, officer: Sr. V.P., Chief Bus. Officer
0.00%4Form 4filed Apr 2, 2021
  1. Last filed Mar 31, 2022; leaving the company requires no filing. Not in the bar.
  2. Last filed Apr 2, 2021; leaving the company requires no filing. Not in the bar.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

12 holders · 70.8K shares · 6 new positions · 6 increased · 0 reduced · 2 closed

HolderShares% outstandingChg q/qFiled
Geode Capital Management, LLC24.4K4.63%+24.4KnewMay 15, 2026
Ikarian Capital, LLC14.4K2.73%0May 15, 2026
Shay Capital LLC14.1K2.68%+14.1KnewMay 15, 2026
XTX Topco Ltd13.3K2.53%+13.3KnewMay 15, 2026
Morgan Stanley2.0K0.39%0May 15, 2026
Tower Research Capital LLC (TRC)1.6K0.31%+1.6KnewMay 15, 2026
UBS Group AG8950.17%+895newMay 5, 2026
Group One Trading, L.P.140.00%0May 13, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Armistice Capital, LLC9.99%13GMay 15, 2025
Mitchell P. Kopin7.70%13GSep 10, 2025

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.